Search Results 2141-2150 of 16384 for Chronic Lymphocytic Leukemia

  1. A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation - Mayo Clinic

    A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic ...

  2. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine: the incidence of hemorrhage in the 3 months following deep vein thrombosis diagnosis in hospitalized malignant ...

  3. Current awards - Center for Clinical and Translational Science

    D. Project title: Multimodal artificial intelligence for breast cancer screening and diagnosis. Tianqiao and Chrissy Chen Established-Investigator Career ...

  4. Cryoglobulinemia - Care at Mayo Clinic

    Mayo Clinic doctors have a worldwide reputation for diagnosis and treatment of rare blood disorders, including cryoglobulinemia. Locations, travel and lodging.

  5. Next Generation Sequencing (NGS) for Diagnosis and Therapy of Patients with Cancer and Hematological Malignancies - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Impaired Renal Function - Mayo Clinic

    Participants with histologically or cytologically confirmed diagnosis of multiple myeloma, as defined in International Myeloma Working Group criteria:.

  7. An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease - Mayo Clinic

    ... severe Crohn's Disease, a chronic bowel disease that causes severe inflammation of the digestive tract. Participation eligibility. Participant eligibility ...

  8. A Study to Assess the Effectiveness, Safety and Tolerability of Dupilumab in Patients with Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) with Type 2 Inflammation - Mayo Clinic

    The primary purpose of this study is to evaluate the effectiveness of dupilumab administered every 2 weeks in patients with moderate-or severe Chronic ...

  9. Focus Areas - Phospholipid Signaling in Embryonic Development and Human Diseases: Kun Ling - Mayo Clinic Research

    Among the three PtdIns4P-5-kinases, PIPKIγ is the only one that causes severe developmental defects and lethality when knocked out in mice. Moreover, a ...

  10. Publications - Tina J. Hieken, M.D. - Mayo Clinic

    ... Lymphatic Reconstruction: A Prospective Trial. ... Long-term outcomes of intraoperatively-placed ... Upgrade at excisional biopsy after a core needle biopsy ...